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Background:  Chronic  total  occlusion  (CTO)  remains  a challenge  in interventional  cardiology.  We  investi-
gated  the  feasibility  and  reliability  of  copper  wire  stents  and  levo-polylactic  acid  (l-PLA)  as  a  means  of
CTO induction  in a porcine  model.
Methods  and  results:  In  one  group  of  20 swine,  copper  stents  were  crimped  on  a 3.0  mm  angioplasty
balloon  and  inserted  into  the  mid-left  anterior  descending  coronary  artery  (LAD).  In the  other  group
of  20  swine,  l-PLA  was  wrapped  on  a guidewire  and  pushed  into  the  distal  LAD with  a 3.0  mm  bal-
loon  catheter  to  induce  embolization.  Of 20 swine  which  underwent  copper  stent  implantation,  13
died  of  stent  thrombosis.  In  the  remaining  7 swine,  total  or near  total  occlusion  with collateral  circu-evascularization lation  was  observed  at 5  weeks.  Of 20 swine  which  underwent  l-PLA  embolization,  4 died  of ventricular
ﬁbrillation  during  or shortly  after  the  procedure.  Serial  histopathologic  studies  showed  complete  absorp-
tion of  the  polymer  with  replacement  by ﬁbrotic  tissue  approximately  4 weeks  following  the  polymer
implantation.
Conclusions:  CTO  could  be reliably  induced  in  porcine  coronary  arteries  by  copper  stents  and  l-PLA.  These
models  may  support  investigation  of  new  percutaneous  devices  to  facilitate  CTO  interventions.
2  Jap© 201
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Recent advances in percutaneous coronary intervention (PCI)
echniques and adjunct pharmacology have improved the out-
omes of patients with coronary artery disease, especially patients
ndergoing reperfusion therapy for acute coronary syndrome
1–3]. However, chronic total occlusion (CTO) remains one of the
ost challenging areas in the ﬁeld of interventional cardiology
4–6]. In an effort to support investigation of new pharmacologi-
al and interventional technologies, a number of studies have been
erformed over the past few decades to develop animal CTO models
7–16]. Copper wire stents induced inﬂammation and microthrom-
osis leading to gradual arterial obstruction [12,17] and in recent
ears bioabsorbable polymers have been utilized to create accurate
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and reproducible CTO [18–20].  In the present study, we sought to
assess the feasibility and reliability of CTO induced by copper wire
stents and levo-polylactic acid (l-PLA), a bioabsorbable polymer, in
a porcine coronary model.
Methods
All studies were approved by the Institutional Animal Care and
Use Committee of Chonnam National University Hospital (CNU
IACUC-H-2008-11). Twenty arteries from 20 swine with copper
wire stenting and 20 arteries from 20 swine with l-PLA injury
were studied. Adult Landraceswine (20–25 kg) were provided and
observed in the laboratory animal care facility of Chonnam National
University Medical Institute for 3–5 days before the experiment. All
swine were given loading doses of aspirin (300 mg)  and clopidogrel
(300 mg) on the morning of the experiment. The procedure was
done under anesthesia with intramuscular injection of a mixture
of zolazepam and tiletamine (2.5 mg/kg, Zoletil®, Virbac, Car-
ros, France), xylazine (3 mg/kg, Rompun®, Bayer AG,  Leverkusen,
Germany), and azaperone (6 mg/kg, Stresnil®, Janssen-Cilag, Neuss,
vier Ltd. All rights reserved.
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iig. 1. Photographs of copper wire stent (A) and bioabsorbable levo-polylactic acid
 sinusoid pattern; (B) l-PLA polymer was  prepared as a sheet that could be cut to t
ermany). A 7F arterial sheath was placed in the left carotid artery
nder local anesthesia with 2% lidocaine. After infusion of 10,000
nits of heparin, a 7F coronary artery guiding catheter was placed
ithin the opening of the coronary artery and baseline coronary
ngiogram was obtained using a mobile C-arm ﬂuoroscopy sys-
em (Phillips BV-25 Gold, Philips Medical Systems, Eindhoven, The
etherlands). Two methods of coronary injury were utilized to
nduce CTO: implantation of copper wire stents and emboliza-
ion by l-PLA. After anesthesia, the pigs were intubated and put
n oxygen supply. When ventricular arrhythmia developed during
he procedure, cardiopulmonary resuscitation was instituted with
irect current shock, cardiac compression, and drug therapy. At the
ame time, mechanical ventilation was started.
opper wire stent-induced injury
Copper wire stent was selected based on previous reports
hat showed copper-induced inﬂammatory reactions and grad-
al obstruction in porcine coronary arteries [12,17]. Copper stents
ere made using 23-gauge copperwire wrapped in a sinusoid pat-
ern identical to that of the WiktorTM (Medtronic, Inc., Minneapolis,
N,  USA) intracoronary stent (Fig. 1A) [12,17]. The copper wire
tent was manually crimped on a 3.0 mm angioplasty balloon and
laced in the mid-left anterior descending coronary artery (LAD) at
–8 atm (Fig. 2A). After stenting, aspirin (100 mg  daily) and clopi-
ogrel (75 mg  daily) were maintained throughout the study period.
ive weeks later, a follow-up coronary angiography was  performed
ccording to the same protocol described above, after which the
wine were killed and the heart was excised for histopathologic
xamination.
ig. 2. Kaplan–Meier estimate of the survival function between copper wire stent
njury and levo-polylactic acid (l-PLA) polymer injury groups.A) polymer (B). (A) Copper wire was  made using 23-gauge copper wire wrapped in
propriate size (5 mm × 10 mm in the present study).
l-PLA-induced injury
l-PLA is a biodegradable polymer known to promote in vivo
angiogenic responses by endothelial cells [21–23] and to induce
thromboﬁbrotic occlusion in porcine coronary arteries [18]. l-PLA
(Resomer® L210S Evonik Industries AG, Essen, Germany) with an
inherent viscosity of 3.3–4.3 dl/g was  purchased. The thin sheet of l-
PLA nanoﬁbers was prepared using an electrospinning technique.
Brieﬂy, l-PLA was  dissolved in 10 ml  of 1,1,1,3,3,3-hexaﬂuoro-2-
propanol (5%, w/v) by vigorous mixing. The resultant solution
was loaded within a syringe ﬁtted to a 21-gauge needle, which
was directly electrospun (ﬂow rate of 2.0 ml/h and a voltage of
14.0–16.0 kV) onto aluminum foil covering a round collector rotat-
ing at 200 rpm. The diameter of the collector was 9 cm and the
distance between the needle and the collector was approximately
23 cm.  After the process, the electrospun ﬁbers were sterilized with
70% ethanol, rinsed with double-distilled water, and dried under an
aseptic condition prior to use. The prepared nanoﬁber sheet could
be cut to the appropriate size as shown in Fig. 1B. l-PLA was cut
into a size of 5 mm × 10 mm with a sharp knife (Fig. 1B), immersed
in saline, manually mounted onto a guidewire, and pushed into
the distal LAD with a 3.0 mm angioplasty balloon. After placement
of the polymer, the guidewire and balloon catheter were removed
and a repeat coronary angiography was  performed to conﬁrm the
successful embolization of the distal LAD by the polymer (Fig. 3A).
The swine was then allowed to recover at the laboratory animal care
facility and underwent a follow-up coronary angiography, followed
by euthanasia and heart excision at 1-week intervals for 6 weeks
to assess the extent of polymer absorption and vessel occlusion (3
swine at 1–5 weeks, 5 swine at 6 weeks). Aspirin (100 mg daily) and
clopidogrel (75 mg  daily) were administered throughout the study
period.
Histopathologic examination
All segments of occluded coronary arteries were sectioned and
stained with hematoxylin–eosin. Histopathologic changes of the
coronary arteries were examined by a cardiovascular pathologist.
Results
Copper wire stent injury
Thirteen swine out of a total of twenty studied died of stent
thrombosis. Acute stent thrombosis occurred in 7 swine and suba-
cute stent thrombosis in 6. Complete follow-up and histopathologic
examination were available in the remaining 7 swine (Fig. 2).
Follow-up coronary angiography at 5 weeks showed total occlu-
sion (in 3 swine) or near-total occlusion (in 4 swine) at the stented
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Fig. 3. Angiograms in anteroposterior view of copper stent injury model. (A) After placement of copper stent in the mid-left anterior descending artery (arrows). (B) Left
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soronary angiogram at 5 weeks showing total occlusion of the stented segment (ar
howing collateral vessels (arrowheads) to the stented segment (arrows).
AD segment with collateral circulation (Fig. 3B and C). Histopatho-
ogic examination showed ﬁbrosis, necrosis, organized thrombus,
nd inﬂammation, particularly near the copper wire (Fig. 4).
-PLA injury
Four swine died of ventricular ﬁbrillation during the procedure
r shortly after placement of the l-PLA polymer. The remaining
6 swine survived until the time of scheduled euthanasia (Fig. 2).
ollow-up coronary angiography after 4 weeks showed total occlu-
ion of the distal LAD with collateral circulation (Fig. 5B and C).
erial histopathologic examination showed gradual absorption of
he l-PLA polymer and formation of thrombus and ﬁbrotic tissue
n the l-PLA injured site (Fig. 6). Total occlusion with complete
bsorption of the polymer occurred approximately 4 weeks after
lacement of the polymer in the porcine coronary artery.
iscussion
PCI for CTO is still associated with a lower success rate and a
igher complication rate compared to PCI for other stenotic lesions
4–6]. Successful induction of CTO similar to that of humans in large
nimal models may  provide useful information on the pathophys-
ologic processes involved in the formation of CTO and may allow
he investigation of new techniques and devices to facilitate the
nterventional procedure for these still challenging lesions.
ig. 4. Hematoxylin–eosin stained sections of copper wire stent injured artery showing 
tent  wires (arrows). (B) After removal of stent wires. with collateral circulation (arrowheads). (C) Right coronary angiogram at 5 weeks
The present study demonstrated successful creation of coro-
nary CTO in a porcine model using copper wire stents and l-PLA,
a biodegradable polymer. Although the histopathology of these
CTO lesions differs from human atherosclerosis, they have poten-
tial utility for evaluating coronary CTO pathophysiology and for
testing new interventional devices. Human CTO histologic ﬁnd-
ings (occlusion duration >1 year) showed loose or dense ﬁbrous
tissue, atheroma (foam cells or pultaceous debris), small vascu-
lar channels, calciﬁed tissue, and focal lymphocyte inﬁltrate [24].
In the present study, copper wire stents induced CTO composed
of ﬁbrosis, necrosis, organized thrombus, and inﬂammation, par-
ticularly near the copper wire. CTO induced by l-PLA showed
ﬁbrous tissue with organized thrombus. Compared to human CTO,
copper wire stent-induced CTO revealed prominent inﬂammation
near the copper wire and l-PLA-induced CTO mainly consisted of
ﬁbrothrombotic occlusions, younger lesions described in humans.
Copper wire stent implantation induced predictable CTO with col-
lateral vessel formation at 5 weeks after stent placement. However,
the inﬂammatory reaction caused by the copper wire entailed a
high incidence of stent thrombosis, leading to increased mortality.
Biodegradable l-PLA polymer placement was equally effective in
producing a reliable and reproducible CTO in a porcine coronary
model. l-PLA successfully induced total coronary occlusion with
lower procedure-related mortality, which may  in part have been
related to the more distal location of l-PLA injury, compared to
copper wire stent injury. The polymer was completely absorbed
complete occlusion of the vessel lumen with ﬁbrotic tissue. (A) Before removal of
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(ig. 5. Angiograms in anteroposterior view of levo-polylactic acid (l-PLA) injury m
olymer (arrows). (B) Left coronary angiogram at 4 weeks demonstrating total occlu
ngiogram at 4 weeks showing collateral vessels (arrowheads) to the LAD.
pproximately 4 weeks after placement in the porcine coronary
rtery.
The induction of CTO by copper wire stents and l-PLA poly-
ers was previously reported [12,17,18].  There were no studies,
owever, which directly compared these two methods using the
ame porcine models and antiplatelet medications in the same
aboratory. In a study by Staab et al. using copper wire stents [17],
igs were premedicated with oral aspirin 650 mg,  32% suffered
eath prior to scheduled euthanasia largely due to procedural
actors, and stenosis of 99% appeared in 17% of the arteries
ig. 6. Serial histopathologic examinations of levo-polylactic acid polymer injured arterie
isible. (B) At 2 weeks, residual polymer is observed in the center of the vessel lumen. (C
D–F)  By 4 weeks, complete occlusion by ﬁbrotic tissue is established (D: 4 weeks, E: 5 we(A) After embolization of the distal left anterior descending artery (LAD) by l-PLA
f the distal LAD (arrows) with collateral circulation (arrowheads). (C) Right coronary
examined. In a study by Prosser et al. using l-PLA polymers [18],
pigs were pretreated with aspirin 325 mg  and clopidogrel 75 mg,
12.5% suffered ventricular ﬁbrillation during the placement of an
l-PLA microporous pledget, and CTO was  successfully induced
in all pigs examined at 28 days. In the present study, pigs were
given aspirin 300 mg  and clopidogrel 300 mg  before the procedure,
followed by aspirin 100 mg  and clopidogrel 75 mg daily throughout
the study period. In copper stent models, 13/20 (65%) died due to
stent thrombosis. However, in all of the 7 pigs which survived until
euthanasia, total or near total occlusion was observed. In l-PLA
s (hematoxylin–eosin staining). (A) At 1 week, unabsorbed polymer plug is clearly
) At 3 weeks, the polymer is nearly absorbed, forming thromboﬁbrotic occlusion.
eks, F: 6 weeks).
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odels, 4/20 (20%) died due to ventricular ﬁbrillation during or
hortly after the procedure. In all pigs that survived and under-
ent euthanasia at 4–6 weeks, total occlusion was  observed. These
esults indicate that copper wire stenting is still associated with
 high incidence of death from stent thrombosis even with use of
ual antiplatelet therapy. In addition, the stent implant may  hinder
evice performance, detracting from the merits of this method for
reating CTO. In contrast, use of l-PLA was associated with much
ower mortality and the polymer was completely absorbed by
 weeks after implantation, obviating the concern for interference
ith device operations. One limitation of this approach may  be that
he polymer plug causes acute occlusion of the coronary artery,
ncreasing the risk of procedure-related death. This problem may
rise from the method used in the present study, in which the
olymer is manually mounted onto the guidewire and may  be
vercome using a polymer scaffold containing multiple pores
hich allow initial blood ﬂow and close over time as thrombosis
nd ﬁbrosis progress, thereby preventing acute vessel occlusion
nd leading to gradual induction of CTO. Prosser et al. demon-
trated successful creation of coronary CTO in a porcine model
y implanting oxygen enhanced three-dimensional microporous
-PLA bioabsorbable polymer constructs, which produced suba-
ute occlusion and formed a thromboﬁbrotic occlusion containing
icrovascular channels [18]. In addition, Suzuki et al. reported that
alciﬁed CTO could be produced in animal coronary and peripheral
rteries by implanting an apatite-coated bioabsorbable polymer
ponge [20]. Incorporating these techniques may  help create a
ore accurate and reproducible CTO in animal models.
In conclusion, CTO could be reliably induced in porcine coronary
rteries by copper wire stents and biodegradable l-PLA polymer.
hese models may  support investigation of new percutaneous
evices to facilitate CTO interventions.
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